378 Citations
Epidemiological Perspectives of Diabetes
- MedicineCell Biochemistry and Biophysics
- 2015
The causes, diagnosis, symptoms, treatment and medications, and epidemiology of diabetes will be described, and the prevalence of type 1 diabetes mellitus has been increased by 2–5 % worldwide and its prevalence is approximately one in 300 in US by 18 years of age.
Diabetes Mellitus and Gestational Diabetes Mellitus
- Medicine
- 2015
Gestational diabetes is the third main form and occurs when pregnant women without a previous history of diabetes develop a high blood glucose level, and usually resolves after the birth of the baby.
Mortality trends of liver cancer among patients with type 2 diabetes at the global and national level.
- MedicineJournal of diabetes and its complications
- 2020
Diabetes and Cancer: Risk, Challenges, Management and Outcomes
- Medicine, BiologyCancers
- 2021
A multidisciplinary approach is important in the management of patients with diabetes and cancer for a better outcome, and future studies are required to better understand the underlying mechanism between the risk of cancer and diabetes.
Insights into the relationships between diabetes, prediabetes, and cancer
- MedicineEndocrine
- 2016
The common soil hypothesis claims that prediabetes and diabetes, as well as metabolic syndrome, may be considered a surrogate sign for dietary risk factors of cancer, and the clepsydra of foods may help choose Foods associated with healthy benefit while avoiding foods associated with harm, including cancer.
Diabetes and cancer: Epidemiological and biological links
- Medicine, BiologyWorld journal of diabetes
- 2020
This minireview consolidates and discusses the epidemiological and biological links between diabetes and various types of cancer, and indicates that diabetes may work as a protective factor for prostate cancer.
Current status of managing diabetes mellitus in Korea
- MedicineThe Korean journal of internal medicine
- 2016
A systematic approach to managing diabetes, including self-management education, is needed to prevent or delay complications, and the government needs to establish a long-term policy to address the growing burden of diabetes.
Bridging Between Disease, Prevalence and Treatment of Diabetes Mellitus : A Review
- Medicine
- 2015
A better understanding concerning the DM and novel approaches in formulation technology and therapy could guide the formulation scientists and clinicians towards successful management of DM.
A Survey on Prescription Pattern of Diabetes Mellitus
- Medicine
- 2017
The aim of the study was to observe what kinds of drugs is prescribed to the diabetic patients and to identify the adherence of the given treatment with the new antidiabetic drugs in this country.
Diabetes Mellitus : Management Challenges , and Prevention
- Medicine
- 2018
Diabetes mellitus (DM), a chronic metabolic disorder with no known cure, is classified into four broad categories: type1, type 2,gestational diabetes and “other specific types”.
References
SHOWING 1-10 OF 17 REFERENCES
Challenges to effective cancer control in China, India, and Russia.
- MedicineThe Lancet. Oncology
- 2014
Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults.
- Medicine, BiologyAmerican journal of epidemiology
- 2004
The findings suggest that diabetes is an independent predictor of mortality from cancer of the colon, pancreas, female breast, and, in men, of the liver and bladder.
Prevalence and control of diabetes in Chinese adults.
- MedicineJAMA
- 2013
The estimated prevalence of diabetes among a representative sample of Chinese adults was 11.6% and the prevalence of prediabetes was 50.1%, which indicates the importance of diabetes as a public health problem in China.
Epidemiology and Molecular Mechanisms Tying Obesity, Diabetes, and the Metabolic Syndrome With Cancer
- Medicine, BiologyDiabetes Care
- 2013
The epidemiological evidence for the association between obesity and cancer is presented, the multiple factors that may play a role in the increased cancer risk and mortality in individuals with obesity, T2D, and the metabolic syndrome are discussed, and changes in hormone and adipokine levels are discussed.
Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women.
- MedicineJournal of the National Cancer Institute
- 1999
The data provide support for the hypothesis that diabetes is associated with an increased risk of colorectal cancer in women and suggest that type 2 diabetes mellitus may increase the risk of this cancer.
Type 2 diabetes and the risk of mortality among patients with prostate cancer
- MedicineCancer Causes & Control
- 2013
The results of this large population-based study indicate that type 2 diabetes is associated with an increased risk of prostate cancer mortality and all-cause mortality, which may signal an association between hyperinsulinemia or other diabetes-associated metabolic derangements and cancer aggressivity.
Diabetes and Cancer: A Consensus Report
- Medicine, BiologyCA: a cancer journal for clinicians
- 2010
A consensus statement of experts assembled jointly by the American Diabetes Association and the American Cancer Society reviews the state of science concerning the association between diabetes and cancer incidence or prognosis and whether diabetes treatments influence the risk of cancer or cancer prognosis.
Diabetes and Cancer
- Medicine, BiologyDiabetes Care
- 2010
A consensus statement of experts assembled jointly by the American Diabetes Association and the American Cancer Society reviews the state of science concerning the association between diabetes and cancer incidence or prognosis and whether diabetes treatments influence risk of cancer or cancer prognosis.
Insulin-lowering effects of metformin in women with early breast cancer.
- MedicineClinical breast cancer
- 2008
Metformin significantly lowers insulin levels, and it improves insulin resistance in nondiabetic women with breast cancer.
GLP1 and cancer: friend or foe?
- Medicine, BiologyEndocrine-related cancer
- 2012
The benefits of using DPP4 inhibitors or GLP1 receptor agonists for treatment of type 2 diabetes outweigh the risks, Nonetheless, their safety profile should be monitored and their indications should be widened cautiously.